An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone taking a prescription for diabetes and weight loss (an oral form of semaglutide sold as Rybelsus, related to Ozempic and Wegovy) noticed that psychedelic mushrooms and even cannabis edibles stopped producing the expected effects. They started wondering if the medication might be blunting the high, because the timing lined up: the altered sensations were gone after they began the drug and returned to being ineffective across several tries. Semaglutide (the active ingredient in Ozempic, Wegovy, and in oral form as Rybelsus) is a drug that copies a natural hormone your gut makes after you eat. That hormone helps control blood sugar and appetite by sending signals to your brain and slowing digestion. It is not a psychedelic and it doesn’t act on the same brain receptors that drugs like psilocybin (the active chemical in “shrooms”) or THC (the main active part of cannabis) do. But because it changes digestion and brain signaling about hunger and fullness, people have wondered if it could also change how other drugs are absorbed or felt. What’s actually known here is mostly anecdote and small-scale observations, not large clinical trials. There are plausible reasons semaglutide could reduce the effects of orally taken drugs. One is altered absorption: semaglutide slows how fast your stomach empties, so a pill or eaten mushroom might reach the gut and bloodstream more slowly and unevenly, possibly lowering peak levels. Another is reduced appetite and changes in gut enzymes or blood flow that could change how much of a drug gets into the circulation. But there isn’t robust published research definitively proving it blocks psychedelics or cannabis; most reports are individual experiences like the one you read. Also, semaglutide is unlikely to directly block the brain receptors psychedelics act on. So the story fits a reasonable biological idea, but it’s not proven. For a regular person, the practical takeaway is cautious awareness. If you’re on semaglutide or similar drugs and rely on consistent effects from oral substances, those effects may be unpredictable. That matters for anyone using prescribed medications, recreational drugs, or microdosing practices because timing, dose, and how the drug is taken (eating versus smoking or injection) can all change outcomes. If you take prescription medication, talk with your prescriber before changing doses or combining substances. They can help assess risks and may suggest safer approaches or note interactions. Important caveats: this is not medical advice and evidence is limited. Slower stomach emptying can alter many oral drugs’ effects, but that doesn’t mean everyone will notice a change. Mixing prescription drugs with psychedelics or cannabis can carry risks—physical or mental—and people with certain health conditions (heart problems, psychiatric histories) are at higher risk from psychedelics or from abrupt changes in medication. Semaglutide is prescription-only and should not be stopped or adjusted without a doctor’s guidance. Bottom line: It’s plausible that Rybelsus/Ozempic-type drugs could blunt the effects of swallowed psychedelics or edibles by changing digestion and absorption, but solid research is lacking, so be careful and consult your clinician.
Source: r/Semaglutide